Companies / Creative Biolabs / "Anti-Glycoprotein Iib/IIIa (X8LX149) h(CD28-CD3_) CAART, pCDCAAR1"
Creative Biolabs

"Anti-Glycoprotein Iib/IIIa (X8LX149) h(CD28-CD3_) CAART, pCDCAAR1" | Creative Biolabs

(0) Write Review

CAAR-Ts represent a targeted approach to therapy of antibody-mediated autoimmune diseases, with the potential for generation of long-term memory CAAR-Ts that can potentially cure disease. Autoantigen-based chimeric immunoreceptors (CAAR) can direct T cells to kill autoreactive B lymphocytes through the specificity of the B cell receptor (BCR). The vector of anti-Glycoprotein Iib/IIIa chimeric autoantigen receptor (CAAR) is constructed for the engineering of T cells to target Human Glycoprotein Iib/IIIa. The T cells are genetically modified through transduction with a lentiviral vector expressing scFv of anti-Glycoprotein Iib/IIIa antibody linked to Immune thrombocytopenic purpura.

Supporting Documents

Data Sheet

Datasheet

Reviews

(0) | Be the first to review this product
No reviews yet

ABOUT THE COMPANY

Creative Biolabs

Creative Biolabs is the leading custom service provider with extensive experience in various antibody production and engineering fields. 

Scientific Products
  • See More
    • Upcoming Virtual Events
    Upcoming Webinars